Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF-episodes in subjects with Parkinson's disease: preliminary results from the Phase-3 study dose titration phase. (January 2018) - Fernandez, H.H.; Isaacson, S.; Espay, A.J.; Pahwa, R.; Truong, D.; Pappert, E.; Agro, A.; Hauser, R.A.